First Dallas Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.8M Buy
4,266
+202
+5% +$80.5K 0.6% 40
2026
Q2
$1.47M Sell
4,064
-89
-2% -$30.5K 0.49% 50
2026
Q1
$1.46M Buy
4,153
+100
+2% +$35.6K 0.54% 44
2025
Q4
$1.33M Sell
4,053
-99
-2% -$31.4K 0.49% 48
2025
Q3
$1.17M Sell
4,152
-963
-19% -$279K 0.44% 51
2025
Q2
$1.43M Sell
5,115
-1,193
-19% -$338K 0.56% 40
2025
Q1
$1.96M Sell
6,308
-949
-13% -$280K 0.82% 34
2024
Q4
$1.89M Sell
7,257
-732
-9% -$217K 0.77% 34
2024
Q3
$2.57M Sell
7,989
-1,460
-15% -$478K 1.08% 27
2024
Q2
$2.95M Sell
9,449
-1,804
-16% -$530K 1.3% 22
2024
Q1
$3.2M Sell
11,253
-525
-4% -$154K 1.47% 19
2023
Q4
$3.39M Buy
11,778
+10,679
+972% +$2.91M 1.75% 11
2023
Q3
$295K Sell
1,099
-9,817
-90% -$2.45M 0.07% 127
2023
Q2
$2.42M Buy
10,916
+625
+6% +$145K 1.35% 18
2023
Q1
$2.49M Buy
10,291
+2,066
+25% +$507K 1.47% 15
2022
Q4
$2.16M Buy
+8,225
New +$2.2M 1.3% 20

Other funds holding AMGN

First Dallas Securities's AMGN Position: Q3 2026 in Review

First Dallas Securities increased its Amgen (AMGN) stake by 5% in Q3 2026, buying an estimated $80.5K and bringing the position to 4,266 shares worth $1.8M. The position accounts for 0.6% of the portfolio, ranked #40.

First Dallas Securities first reported a position in AMGN in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.39M in Q4 2023. 2,885 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • First Dallas Securities held 4,266 shares of Amgen worth $1.8M as of Q3 2026.
  • First Dallas Securities bought 202 Amgen shares in Q3 2026, an estimated $80.5K.
  • Amgen made up 0.6% of First Dallas Securities's portfolio in Q3 2026, its #40 holding.
  • First Dallas Securities first reported a position in Amgen in Q4 2022 and has held it in 16 quarters since.
  • First Dallas Securities's Amgen position peaked at $3.39M in Q4 2023.
  • 2,885 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on First Dallas Securities's 13F filing for Q3 2026, filed 13 Nov 2026.